This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Xylo Technologies Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Liron Carmel

Algemeen directeur

US$451.0k

Totale compensatie

Percentage CEO-salaris	37.5%
Dienstverband CEO	5.3yrs
Eigendom CEO	0.005%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	5.8yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Liron Carmel's beloning veranderd ten opzichte van Xylo Technologies's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Dec 31 2023	US$451k	US$169k	-US$16m
Sep 30 2023	n/a	n/a	-US$15m
Jun 30 2023	n/a	n/a	-US$14m
Mar 31 2023	n/a	n/a	-US$12m
Dec 31 2022	US$451k	US$216k	-US$10m
Sep 30 2022	n/a	n/a	-US$8m
Jun 30 2022	n/a	n/a	-US$7m
Mar 31 2022	n/a	n/a	US$107k
Dec 31 2021	US$516k	US$201k	US$7m
Sep 30 2021	n/a	n/a	US$7m
Jun 30 2021	n/a	n/a	US$8m
Mar 31 2021	n/a	n/a	US$2m
Dec 31 2020	US$214k	US$139k	-US$4m
Sep 30 2020	n/a	n/a	-US$10m
Jun 30 2020	n/a	n/a	-US$15m
Mar 31 2020	n/a	n/a	-US$15m
Dec 31 2019	US$202k	US$102k	-US$14m

Compensatie versus markt: De totale vergoeding ($USD 451.00K ) Liron } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 486.57K ).

Compensatie versus inkomsten: De vergoeding van Liron is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Liron Carmel (39 yo)

5.3yrs

Tenure

US$451,000

Compensatie

Mr. Liron Carmel is a Director at Viewbix Inc. since September 19, 2022. He has been Director at Matomy Media Group Ltd. since May 13, 2020 and Polyrizon Ltd.from July 2020. Mr. Carmel has been Chief Exec...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Smadar Cohen	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Eliyahu Yoresh	Independent Chairman of the Board	5.8yrs	US$404.00k	0.029% € 952.4
Ronen Rosenbloom	Independent Director	5.8yrs	US$70.00k	geen gegevens
Eli Cohen	Independent Director	5.8yrs	US$76.00k	geen gegevens
Kineret Tzedef	Independent Director	5.1yrs	US$71.00k	geen gegevens
Nancy Agmon-Levin	Member of Scientific Advisory Board	2.3yrs	geen gegevens	geen gegevens
Avi Schroeder	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Fabio Sonvico	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens

5.8yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 2QM wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.8 jaar).

This company listing is no longer active

Xylo Technologies Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Medigus Ltd., Annual General Meeting, Aug 07, 2023

Medigus Ltd., Annual General Meeting, Jun 16, 2022

Tatiana Yosef to Step Down as Chief Financial Officer of Medigus Ltd., with Effect from January 15, 2021

Recent updates

New major risk - Revenue and earnings growth

Full year 2023 earnings released: US$9.50 loss per share (vs US$6.04 loss in FY 2022)

Medigus Ltd.(NasdaqCM:MDGS) dropped from NASDAQ Composite Index

New minor risk - Financial data availability

Medigus Ltd. Announces Launch of Unique Pilot of A Wireless Charging Solution

New major risk - Market cap size

Medigus Ltd., Annual General Meeting, Aug 07, 2023

existing shareholders and office holders in ScoutCam acquired 46.11% stake in ScoutCam Inc. (OTCPK:SCTC) from Medigus Ltd. (NasdaqCM:MDGS) for $6 million.

M. Arkin (1999) Ltd. acquired 46.11% stake in ScoutCam Inc. (OTCPK:SCTC) from Medigus Ltd. (NasdaqCM:MDGS) for $6 million.

Medigus Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

First half 2022 earnings released: US$0.15 loss per share (vs US$0.44 profit in 1H 2021)

Medigus Announces Receipt of Nasdaq Notice of Bid Price Deficiency

Medigus Ltd., Annual General Meeting, Jun 16, 2022

Full year 2021 earnings released: EPS: US$0.20 (vs US$0.65 loss in FY 2020)

Medigus Ltd. (NasdaqCM:MDGS) acquired a 35.1% stake in Fuel Doctor Holdings, Inc. (OTCPK:FDOC) for $0.26 million.

Medigus Ltd. Micro Mobility Vehicle JV, Revoltz, Launches Pilot Program At A New Autonomous Supermarket

A consortium of investors led by Medigus Ltd. (NasdaqCM:MDGS), L.I.A. Pure Capital Ltd. along with other buyers including a group of individuals completed the acquisition of ParaZero Technologies Ltd from Delta Drone International Limited (ASX:DLT).

Medigus Ltd. Announces First Authorization for Commercial Drone Deliveries in Brazil

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First half 2021 earnings released: EPS US$0.44 (vs US$0.56 loss in 1H 2020)

Medigus Joint Venture, Revoltz Completes First Micromobility Vehicle Functional Prototype

Medigus Ltd. announced delayed 20-F filing

Medigus Forms Joint Venture for the Development of Urban and Logistics Electric Vehicles with Emuze Founders

Medigus Ltd. Initiates Development of Robotic Wireless Charging Pad for Electric Vehicles

Medigus Ltd. Enters the Wireless Charging Market for Electric Vehicle with New Autonomous Technology

Medigus Ltd. (TASE:MDGS) completed the acquisition of 50.01% stake in Purex Incorporated and Smart Repair Pro, Inc.

Tatiana Yosef to Step Down as Chief Financial Officer of Medigus Ltd., with Effect from January 15, 2021

Medigus Signs MOU to Enter Electric Vehicles and Electric Charging Market

Medigus Ltd. (TASE:MDGS) signed a share purchase agreement to acquire an unknown stake in Eventer Technologies Ltd.

Medigus Ltd. (TASE:MDGS) agreed to acquire additional 15.1% stake in Gix Internet Ltd (TASE:GIX).

Medigus Ltd. (TASE:MDGS) signed a non-binding letter of intent to acquire a controlling interest of 50.1% in Purex Incorporated and Smart Repair Pro, Inc. for $2.5 million.

Medigus Ltd. (TASE:MDGS) completed the acquisition of Linkury LTD. from Algomizer Ltd (TASE:ALMO).